Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Catalent Inc (NY: CTLT )

55.99 +0.02 (+0.03%)
Streaming Delayed Price Updated: 12:13 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Catalent Inc

< Previous 1 2 3 4 5 Next >
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results
From Catalent, Inc.
Via Business Wire
Robbins LLP Reminds Stockholders it is Investigating the Acquisition of Catalent, Inc. (CTLT)
From Robbins LLP
Via Business Wire
Robbins LLP is Investigating the Acquisition of Catalent, Inc. (CTLT) by Novo Holdings
From Robbins LLP
Via GlobeNewswire
Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment
From Catalent, Inc.
Via Business Wire
CATALENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalent, Inc. - CTLT
From Kahn Swick & Foti, LLC
Via Business Wire
S&P 500's surge to new highs: Bull trap hiding in plain sight?
Nvidia and Meta lead the S&P 500 rally, but there's cause for concern about a potential bull trap amid market volatility and a pivot to stable dividend payers. 
Via MarketBeat
Topics ETFs Economy Stocks
Exposures Interest Rates US Equities
Catalent, Inc. Reports Second Quarter Fiscal 2024 Results
From Catalent, Inc.
Via Business Wire
Can financial, healthcare, energy stocks rise as rates stay high?
Sectors including financials, healthcare, utilities and energy outperform as interest rates remain high, but some of those industries face challenges in 2024. 
Via MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Catalent, Inc. (NYSE – CTLT), Everbridge, Inc. (Nasdaq – EVBG), Slam Corp. (Nasdaq – SLAM), Karuna Therapeutics, Inc. (Nasdaq – KRTX)
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of Catalent; Is $63.50 a Fair Price?
From Johnson Fistel, LLP
Via Business Wire
CTLT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Catalent, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Novo Holdings to Acquire Catalent
From Catalent, Inc.
Via Business Wire
Catalent, Inc. Announces Second Quarter Fiscal Year 2024 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
Catalent Commits to Reducing Greenhouse Gas Emissions by 2030
From Catalent, Inc.
Via Business Wire
Catalent, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Catalent, Inc.
Via Business Wire
Catalent Announces Closing of Incremental Term Loans
From Catalent, Inc.
Via Business Wire
Catalent Regains Compliance with NYSE Continued Listing Standards
From Catalent, Inc.
Via Business Wire
Catalent, Inc. Reports Preliminary First Quarter Fiscal 2024 Results and Reaffirms Full-Year Fiscal 2024 Guidance
From Catalent, Inc.
Via Business Wire
Sotera Health Appoints Karen Flynn to Board of Directors
From Sotera Health Services, LLC
Via GlobeNewswire
Catalent, Inc. Announces First Quarter Fiscal Year 2024 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Flee to Healthcare Stocks if Recession Rears its Head?
In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends. 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Catalent Appoints David McErlane as Biologics Segment Leader
From Catalent, Inc.
Via Business Wire
Catalent Receives NYSE Notice Regarding Late Form 10-K Filing
From Catalent, Inc.
Via Business Wire
Catalent, Inc. to Present at September Investor Conferences
From Catalent, Inc.
Via Business Wire
Catalent Announces Governance Enhancements and New Initiatives to Drive Value
From Catalent, Inc.
Via Business Wire
Catalent, Inc. Reports Preliminary Fourth Quarter and Fiscal 2023 Results
From Catalent, Inc.
Via Business Wire
Catalent, Inc. Announces Fourth Quarter Fiscal Year 2023 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Rising Dividend Make Zoetis a Doggone Winner
Investors that typically focus on other large cap pharmaceutical plays may wish to consider an alternative bet on pets with shares of Zoetis. 
Via MarketBeat
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.